Oct 24, 2019 6:37 AM
BACK TO TOP
KSE 100
33,439.69
240.73
(0.73%)
KSE ALL
24,304.12
209.64
(0.87%)
KSE 30
15,616.11
128.88
(0.83%)
KMI 30
54,092.83
589.96
(1.10%)
KMI ALL
15,842.84
148.45
(0.95%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.308.97
-5.80
(-1.84%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Oct 23, 2019 3:38 PM
REG
FUT
ODL
Open
319.99
High
328.00
Low
302.10
Volume
18,400
CIRCUIT BREAKER
299.04 — 330.50
DAY RANGE
302.10 — 328.00
52-WEEK RANGE
302.10 — 710.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
314.77
VAR
14.30
HAIRCUT
19.25
P/E Ratio (TTM)
21.67
1-Year Change *
-41.15%
YTD Change *
-51.04%
Open
325.00
High
325.00
Low
313.00
Close
313.00
Change
-0.56%
LDCP
314.77
Volume
152
Total Trades
7
CIRCUIT BREAKER
283.30 — 346.24
DAY RANGE
313.00 — 325.00
Ask Price
317.99
Ask Volume
15
Bid Price
310.00
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited (the Company) is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of research based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Munir A. ShaikhChairman
Mr. Syed Anis AhmedCEO
Mr. Malik SaadatullahCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

Ernst & Young Ford Rhodes Sidat Hyder & Company, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
30,248,256.31
Shares
97,900,302
Free Float
21,021,373
Free Float
21.47%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 17, 2019Financial Results For The 3rd Quarter View   PDF
Aug 16, 2019Financial Results for the Quarter ended June 30, 2019 View   PDF
Apr 30, 20191st Quarter Accounts for the period ended March 31, 2019 View   PDF
Apr 23, 2019Financial Results for the 1st Quarter ended 2019-03-31 View   PDF
Mar 29, 2019Annual Report for the year ended December 31, 2018 View   PDF
Feb 21, 2019Financial Rsults for year ended December 31 2018 View   PDF
Oct 26, 2018Quarterly Report for the period ended September 30, 2018 View   PDF
Aug 17, 2018Financial Results for the half year ended June 30 2018 View   PDF
Feb 26, 2018Abbott Financial Results 2017 View   PDF
Aug 21, 2017Financial Results for the Half year ended 2017-06-30 View   PDF
DateTitleDocument
Oct 10, 2019Board Meeting View   
Aug 9, 2019Board Meeting View   
Apr 16, 2019Board Meeting View   
Mar 20, 2019Notice of Annual General Meeting View   PDF
Feb 14, 2019Board of Directors Meeting View   
Oct 12, 2018Board Meeting View   
Aug 10, 2018Board Meeting View   
Apr 16, 2018Board Meeting View   
Feb 19, 2018Board Meeting View   
Oct 12, 2017Board Meeting View   
DateTitleDocument
Aug 27, 2019Transmission of Quarterly Report View   PDF
May 14, 2019Credit of Final Cash Dividend View   
Oct 19, 2018Financail Results for the 3rd Quarter 2018 View   PDF
Sep 25, 2018Credit of Interim Cash Dividend View   
Aug 29, 2018Transmission of 2nd Quarter Report View   PDF
May 18, 2018Credit of Final Cash Dividend View   
Apr 23, 2018Q!2018 results View   PDF
Mar 20, 2018Notice of AGM View   PDF
Jan 4, 2018Information under Regulation No. 5.6.1 (d) of PSX Rule Book View   PDF
Jan 3, 2018Information under Regulation No. 5.6.1 (d) of PSX Rule Book View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2018201720162015
Sales29,719,27926,088,23323,387,91521,170,446
Profit after Taxation2,694,3334,205,2324,021,7923,586,736
EPS27.5242.9541.0836.64
Q3 2019Q2 2019Q1 2019Q3 2018
Sales6,974,8318,089,7237,215,7997,816,598
Profit after Taxation265,791178,777327,669817,933
EPS2.711.833.358.35
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2018201720162015
Gross Profit Margin (%)32.8938.6740.0538.86
Net Profit Margin (%)9.0716.1217.2016.94
EPS Growth (%)(35.93)4.5512.1227.35
PEG(0.64)3.571.920.63

Payouts

DateFinancial ResultsDetailsBook Closure
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016
August 17, 2015 1:36 PM30/06/2015(HYR) 100% (D) 04/09/2015 - 11/09/2015
February 24, 2015 1:46 PM31/12/2014(YR) 48% (D) 16/04/2014 - 23/04/2014
August 21, 2014 2:16 PM30/06/2014(HYR) 30%(I) (D) 08/09/2014 - 15/09/2014

Financial Reports